These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6410447)

  • 1. Mianserin: cardiovascular effects in elderly patients.
    Møller M; Thayssen P; Kragh-Sørensen P; Pedersen OL; Kristensen CB; Bjerre M; Benjaminsen S; Gram LF
    Psychopharmacology (Berl); 1983; 80(2):174-7. PubMed ID: 6410447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular effects of mianserin--a comparative study with amitriptyline and a placebo in healthy subjects.
    Kopera H; Fluch N; Harpf H; Klein WW; Stulemeijer SM
    Int J Clin Pharmacol Ther Toxicol; 1980 Mar; 18(3):104-9. PubMed ID: 7380584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular effects of amitriptyline, mianserin, zimelidine and nomifensine in depressed patients.
    Burgess CD; Montgomery S; Wadsworth J; Turner P
    Postgrad Med J; 1979 Oct; 55(648):704-8. PubMed ID: 537956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular effects of mianserin and amitriptyline in healthy volunteers.
    Wester HA; Siegers CP
    Int J Clin Pharmacol Ther Toxicol; 1980 Dec; 18(12):513-7. PubMed ID: 7228446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic studies on mianserin and its interaction with clonidine.
    Elliott HL; McLean K; Sumner DJ; Reid JL
    Eur J Clin Pharmacol; 1981; 21(2):97-102. PubMed ID: 7341285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of an effect of mianserin on the actions of clonidine or methyldopa in hypertensive patients.
    Elliott HL; McLean K; Sumner DJ; Reid JL
    Eur J Clin Pharmacol; 1983; 24(1):15-9. PubMed ID: 6299752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of mianserin on cardiac conduction.
    Burrows GD; Davies B; Hamer A; Vohra J
    Med J Aust; 1979 Jul; 2(2):97-8. PubMed ID: 492044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular responses to mianserin hydrochloride: a comparison with tricyclic antidepressant drugs.
    Burgess CD; Turner P; Wadsworth J
    Br J Clin Pharmacol; 1978; 5 Suppl 1(Suppl 1):21S-28S. PubMed ID: 341940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EEG, blood level, and behavioral effects of the antidepressant mianserin (ORG GB-94).
    Fink M; Irwin P; Gastpar M; DeRidder JJ
    Psychopharmacology (Berl); 1977 Nov; 54(3):249-54. PubMed ID: 413141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular effects of amitriptyline in the treatment of elderly depressed patients.
    Christensen P; Thomsen HY; Pedersen OL; Thayssen P; Oxhøj H; Kragh-Sørensen P; Gram LF
    Psychopharmacology (Berl); 1985; 87(2):212-5. PubMed ID: 3931149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of the electrocardiographic effects of phenelzine, tricyclic antidepressants, mianserin, and placebo.
    McGrath PJ; Blood DK; Stewart JW; Harrison W; Quitkin FM; Tricamo E; Markowitz J
    J Clin Psychopharmacol; 1987 Oct; 7(5):335-9. PubMed ID: 3680604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The psychopharmacological effects of repeated doses of fluvoxamine, mianserin and placebo in healthy human subjects.
    Curran HV; Lader M
    Eur J Clin Pharmacol; 1986; 29(5):601-7. PubMed ID: 3082644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular tolerance of mianserin and interactions of mianserin with other drugs.
    Kopera H
    Acta Psychiatr Belg; 1978; 78(5):787-97. PubMed ID: 375683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaco-EEG study of 6-azamianserin (ORG 3770): dissociation of EEG and pharmacologic predictors of antidepressant activity.
    Fink M; Irwin P
    Psychopharmacology (Berl); 1982; 78(1):44-8. PubMed ID: 6815696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrocardiographic changes during treatment with maprotiline and mianserin.
    Goldie A; Edwards JG
    Neuropharmacology; 1984 Feb; 23(2B):273-5. PubMed ID: 6709129
    [No Abstract]   [Full Text] [Related]  

  • 16. Mianserin: result of a decade of antidepressant research.
    De Ridder JJ
    Pharm Weekbl Sci; 1982 Oct; 4(5):139-45. PubMed ID: 6128715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular effects of bupropion in depressed patients with heart disease.
    Roose SP; Dalack GW; Glassman AH; Woodring S; Walsh BT; Giardina EG
    Am J Psychiatry; 1991 Apr; 148(4):512-6. PubMed ID: 1900980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the interaction between mianserin and centrally-acting antihypertensive drugs.
    Elliott HL; Whiting B; Reid JL
    Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):323S-328S. PubMed ID: 6824563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mianserin: a review of its pharmacological properties and therapeutic efficacy in depressive illness.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1978 Oct; 16(4):273-301. PubMed ID: 359311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mianserin: a decade of scientific development.
    Peet M; Behagel H
    Br J Clin Pharmacol; 1978; 5 Suppl 1(Suppl 1):5S-9S. PubMed ID: 623702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.